Image

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Study on long-term effects of early HIV treatment in children.

Recruiting
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study follows children with HIV who received early treatment to learn more about their health over time. Early treatment means they started taking at least three anti-HIV medicines (called ARV agents) within 12 weeks after birth. The study lasts for about seven years and involves 250 children who will have check-ups twice a year. During these visits, doctors will check the children's health and collect samples for future research.

To join, children must have been part of an earlier study, have confirmed HIV, and started early treatment. Parents or guardians must agree to the study and expect the child to be available for follow-up for at least two years. Kids can join if they don't have any serious health problems that could make the study unsafe.

  • Commitment: Participation requires follow-ups every six months for seven years.
  • No Treatment Given: This study observes, it does not provide treatment.
  • Eligibility: Must have started HIV treatment within 12 weeks of birth.
Print
Study details
    HIV Infection

NCT05154513

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

3 May 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.